Cochlear
-
Press Releases
Cochlear introduces the new Osia® 3 Sound Processor
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announces FDA clearance of the new Cochlear® Osia® 3 Sound Processor the newest advancement of the award-winning Osia System.‡ Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). The Osia 3 Sound Processor is the first fully rechargeable…
Read More » -
Press Releases
Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 Sound Processor and the new non-surgical Baha SoundBand™. Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). Baha 7 Sound Processor in…
Read More » -
Press Releases
Cochlear obtains FDA approval of Kanso 2 Sound Processor, first off-the-ear cochlear implant sound processor with direct smartphone connectivity
LONE TREE, Colo., July 6, 2020 /PRNewswire/ — Cochlear Limited (ASX:COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology solutions. The approval of the Cochlear™ Nucleus® Kanso® 2 Sound Processor, Nucleus® 7 Sound Processor for Nucleus 22 Implant recipients and Custom Sound® Pro fitting software reflects Cochlear’s ongoing commitment…
Read More »